2m 2m 2m 2m 2m 2m 2m
INDIVIOR PHARMA (INDV)
NASDAQ
$41.49+$1.48 (+3.70%)
Price as of Aug 03, 2026 8:57 AM EDT- $4.7BMarket Cap
- 90.07%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INDIVIOR PHARMA (INDV)
$41.49+$1.48 (+3.70%)
INDV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $40.01 | ||
Change | -$0.21 (-0.52%) | ||
Open | $39.96 | ||
High | $40.30 | ||
Low | $38.63 | ||
Previous Close | $40.22 | ||
Volume | 1,349,424 | ||
30-Day Average Volume | 1,529,146 | ||
1-Week Change | -1.27% | ||
1-Month Change | -2.49% | ||
1-Year Change | 90.07% | ||
3-Year Change | 79.98% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 118.2M | ||
Total Assets | $1.2B | ||
Market Cap | $4.7B | ||
Enterprise Value | $5.0B | ||
Period: QTR TTM FY | |||
Revenue | $317.0M | ||
Net Income | $89.0M | ||
Free Cash Flow | -$29.0M | ||
EBIT | $115.0M | ||
EBITDA | $117.0M | ||
Net Working Capital | -$112.0M | ||
EPS | $0.69 | ||
Enterprise Value/EBITDA | 43 | ||
Enterprise Value/Revenue | 16 | ||
P/B | -33 | ||
P/E | 58 | ||
PEG | -5 | ||
Price/Free Cash Flow | -163 | ||
Price/Operating Cash Flow | -525 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue